Finally, we integrate this information with clinically annotated human transcriptomic data supporting that (f) extracellular carbonic anhydrases improve survival of patients with HER2-enriched breast cancer in a manner that depends on the chronic inflammatory profile of the tumor tissue. The gene discussed is ERBB2; the disease is breast carcinoma.